51 studies found for:    Open Studies | "Pigmentation Disorders"
Show Display Options
Rank Status Study
1 Unknown  Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
Conditions: Surgical Wound;   Hypo-pigmented Skin
Intervention: Device: Momelan Technologies Epidermal Graft Harvesting System
2 Unknown  Punchgrafting Techniques for Vitiligo
Conditions: Non-segmental Vitiligo;   Segmental Vitiligo;   Piebaldism
Intervention: Procedure: punchgrafting
3 Recruiting Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism
Conditions: Albinism;   Oculocutaneous Albinism;   Foveal Hypoplasia;   Hypopigmentation;   Nystagmus
Intervention:
4 Unknown  Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
Condition: Kidney Failure, Chronic
Intervention: Drug: vitamin C, intravenous injection
5 Recruiting Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Conditions: Aggressive Systemic Mastocytosis;   Mast Cell Leukemia;   Systemic Mastocytosis
Interventions: Drug: brentuximab vedotin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Other: questionnaire administration
6 Recruiting A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis
Condition: Hermansky Pudlak Syndrome
Interventions: Other: Pulmonary function test;   Other: Chest CT;   Other: Sample collection
7 Not yet recruiting SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)
Conditions: Myelofibrosis;   Chronic Myelomonocytic Leukemia;   Advanced Systemic Mastocytosis;   Advanced Symptomatic Primary Eosinophilic Disorder
Intervention: Drug: SL-401
8 Unknown  Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Dietary Supplement: GINGKO BILOBA
9 Unknown  Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
Conditions: Patients With Active Non-segmental Vitiligo.;   Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05%;   Cream Compared to NB-UVB Alone in Patients With Non-segmental Vitiligo
Intervention: Drug: Fluticasone proprionate 0.05% cream
10 Unknown  Molecular Mechanisms and Diagnosis of Mastocytosis
Condition: Mastocytosis
Intervention:
11 Not yet recruiting Fractional Laser in Combination With UVB Therapy in Vitiligo Patients
Condition: Vitiligo
Interventions: Device: Fractional CO2 laser;   Other: NB-UVB therapy;   Drug: Fluticasone Propionate Cream 0.05%
12 Unknown  Xeroderma Pigmentosum Patient Experiences
Condition: Xeroderma Pigmentosum
Intervention: Other: Survey Study
13 Not yet recruiting A Prospective Multi-Center Study Using Laser for the Treatment of Melasma and Lentigines in Asian Skin
Conditions: Melasma;   Lentigines
Intervention: Device: enLighten Laser
14 Recruiting Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study
Condition: Idiopathic Guttate Hypomelanosis
Intervention: Device: Excimer Light Treatment
15 Recruiting Vision Response to Dopamine Replacement
Conditions: Albinism;   Oculocutaneous Albinism
Intervention: Drug: Levodopa/carbidopa
16 Recruiting Photocil (Topical) for the Treatment of Vitiligo
Condition: Vitiligo
Interventions: Drug: Photocil for Vitiligo;   Other: Placebo - Sunscreen (SPF 2)
17 Recruiting Efficacy of Red Light in Vitiligo
Condition: Vitiligo
Intervention: Procedure: Red light
18 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)
19 Unknown  Evaluation of Response of Dasatinib to Treat Mastocytosis
Condition: Systemic Mastocytosis
Intervention: Drug: Dasatinib
20 Recruiting Use of Tamoxifen in Systemic Mastocytosis
Condition: Systemic Mastocytosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years